| Kathy Truong, PHARM D | |
|
4029 43rd Street, Suite 700, San Diego, CA 92105-1510 | |
| (619) 521-9753 | |
| (619) 521-4837 |
| Full Name | Kathy Truong |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4029 43rd Street, San Diego, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003193004 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 61721 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathy Truong, PHARM D 4029 43rd Street, Suite 700, San Diego, CA 92105-1510 Ph: (619) 521-9753 | Kathy Truong, PHARM D 4029 43rd Street, Suite 700, San Diego, CA 92105-1510 Ph: (619) 521-9753 |
News Archive
The Wall Street Journal/Dow Jones: Health and Human Services Secretary Kathleen Sebelius spoke earlier today at the America's Health Insurance Plans' national policy forum in Washington, D.C. and "warned health insurers Wednesday that opposing President Obama's health-care agenda and letting premium hikes continue would eventually hurt the health-care industry. ... Sebelius cautioned in stark terms that, if insurers opposed Democrats' health-care legislation, premiums hikes would continue and more small businesses would drop health coverage for their employees" (Yoest, 3/10).
Through their pattern of firing, neurons influence the behavior of the cells that upon maturation will provide insulation of neuronal axons, according to a new study publishing 22 August in the open access journal PLOS Biology by Balint Nagy, Maria Kukley and colleagues at the University of Tübingen, Germany.
Mirna Therapeutics, Inc., a leading developer of microRNA (miRNA)-based therapeutics, announced today that it will present new data at the inaugural CPRIT Innovations in Cancer Prevention and Research Conference, November 17-19, 2010 in Austin, TX.
A research team of the UNN Faculty of Chemistry led by Professor Alexei Fedorov has developed and synthesized a new multifunctional compound that possesses anti-tumor properties that are due to several independent effects.
In response to reports that women may be using an unapproved drug, domperidone, to increase milk production (lactation), the Food and Drug Administration (FDA) is warning breastfeeding women not to use this product because of safety concerns. Today, FDA also issued six letters to pharmacies that compound products containing domperidone and firms that supply domperidone for use in compounding.
› Verified 9 days ago
Kristen A Cote, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6405 El Cajon Blvd, San Diego, CA 92115 Phone: 619-286-8397 | |
Camthi Sager, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6405 El Cajon Blvd, San Diego, CA 92115 Phone: 619-286-3470 Fax: 619-286-2063 | |
Richard Fung, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4647 Zion Ave, San Diego, CA 92120 Phone: 626-278-2749 | |
Dr. Jennifer Ingrid Purificacion, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 University Ave, San Diego, CA 92103 Phone: 619-295-6688 | |
Ms. Misty Laree Cole, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8766 Navajo Rd, San Diego, CA 92119 Phone: 619-667-8764 | |
Tammy Minh Tran, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16773 Bernardo Center Dr, San Diego, CA 92128 Phone: 858-451-2630 |